Great article by a leading MS researcher. He discusses its use and drawbacks. -D
Please note that I do think the data supports AHSCT as being the most effective treatment we have for MS. However, this is not really the question. The main question the MS community needs to answer is whether or not the risks are justified and who should be taking the risks?
https://gavingiovannoni.substack.com...tm_source=copy
https://gavingiovannoni.substack.com...tm_source=copy